CVS Health broadens consumer access to GLP-1 weight management
Offers all FDA approved GLP-1s, whether through insurance or cash-pay options.
Offers all FDA approved GLP-1s, whether through insurance or cash-pay options.
The company said sales growth was tempered by the Medicare Maximum Fair Price (MFP) program, which took effect Jan. 1 and reduced prices on 10 prescription drugs.
More pharmacy staff, online scheduling and flexible appointment options make it easy for individuals and families to get vaccinated at no cost with most insurance.
The CARIN Code of Conduct for Consumer-Facing Applications Accreditation from DirectTrust affirms Health100’s commitment to privacy, transparency, and consumer data stewardship
New Mexico ranks first as provider shortages, coverage gaps, and prescription costs create barriers to medication access.
New store marks a key step in the community and ensures access to essential pharmacy and retail services for residents.
Legislation codifies FDA's science-based approach to biosimilar review by limiting comparative efficacy studies; Introduced and passed House Committee this week.
The company’s community health investments are expanding access to housing, care and essential resources across the Commonwealth.
Legislative progress codifies FDA's science-based approach to biosimilar review by limiting comparative efficacy studies; Eliminates arbitrary distinction between interchangeable biologics and biosimilars.
Strategic integration embeds multi-card discount pricing directly into veterinary e-prescribing workflows, expanding affordability and price transparency for pet owners at the pharmacy counter.
The deferral amounts are roughly $867.5 million for California and $199 million for Minnesota, as reviews identified claims that require further scrutiny before matching funds are released.
Aims to help patients find affordable GLP-1 medication options.
The company will acquire the Diabetes Health business of AdaptHealth Corp., and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments.
Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences.
"Pharmacists believe in innovation, but innovation must be grounded in science and patient safety," said Brigid Groves, vice president of professional affairs at APhA.
The program follows the recent launch of Medicare’s new GLP-1 Bridge program.